This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wichitwechkarn, J. Articles by Peerapakorn, S. Search for Related Content PubMed PubMed Citation Articles by Wichitwechkarn, J. Articles by Peerapakorn, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 01 1995, 45-49, Vol 33, No. 1
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Detection of Mycobacterium leprae infection by PCR

J Wichitwechkarn, S Karnjan, S Shuntawuttisettee, C Sornprasit, K Kampirapap and S Peerapakorn
Raj-pracha-samasai Institute, Leprosy Division, Soi Bamrasnaradoon Hospital, Nonthaburi, Thailand.

PCR amplification of the 531-bp fragment of the Mycobacterium leprae pra gene in fresh biopsy and slit skin smear samples was evaluated for its usefulness in the detection of leprosy bacilli in patients in Thailand. In multibacillary patients, 87.1% (27 of 31) of biopsy specimens and 41.9% (13 of 31) of slit skin smear specimens were positive by PCR, whereas in paucibacillary patients, 36.4% (8 of 22) of biopsy specimens and 18.2% (4 of 22) of slit skin smear specimens yielded detectable PCR amplification. Compared with other diagnostic procedures, PCR showed a clear advantage over both microscopic examination of slit skin smears and serologic detection of anti- phenolic glycolipid 1 antibody, especially in paucibacillary patients when bacterial indexes were 0 and seropositivity was only 6.25%. PCR was also evaluated for its potential to help monitor bacterial clearance in some of these patients during chemotherapeutic treatment. The PCR results on slit skin smear samples at 1, 3, and 6 months of chemotherapy showed that the number of PCR-positive cases of both multibacillary and paucibacillary types decreased sequentially. The results of this study are encouraging. However, investigation of a larger number of clinical specimens with an improvement in PCR methods, especially on slit skin smears, needs to be done before PCR can be established as a diagnostic procedure for leprosy patients and subclinical cases or as a tool for drug assessment.

This article has been cited by other articles:

• CHAE, G.-T., KIM, M.-J., KANG, T.-J., LEE, S.-B., SHIN, H.-K., KIM, J.-P., KO, Y.-H., KIM, S.-H., KIM, N.-H. (2002). DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy. J Med Microbiol 51: 417-422 [Abstract] [Full Text]  
• Ruiz-Manzano, J., Manterola, J.-M., Gamboa, F., Calatrava, A., Monso, E., Martinez, C., Ausina, V. (2000). Detection of Mycobacterium tuberculosis in Paraffin-Embedded Pleural Biopsy Specimens by Commercial Ribosomal RNA and DNA Amplification Kits. Chest 118: 648-655 [Abstract] [Full Text]